Nature Reviews Drug Discovery 16, 152–154 (2017)
The article has been updated to indicate that Sandoz ran a confirmatory study in chronic plaque psoriasis of its etanercept biosimilar versus active comparator, rather than versus placebo.
Additional information
The online version of the original article can be found at 10.1038/nrd.2017.36
Rights and permissions
About this article
Cite this article
Mullard, A. Erratum: Bracing for the biosimilar wave. Nat Rev Drug Discov 16, 367 (2017). https://doi.org/10.1038/nrd.2017.64
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.64
